Document:

EX-10.36

 Exhibit 10.36 
  

 
  

UPLAND SOFTWARE, INC. 

SERIES C PREFERRED STOCK PURCHASE AGREEMENT 

December 20, 2013 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	SECTION 1 AUTHORIZATION, SALE AND ISSUANCE	  	 	1	  
			
	            1.1	  	 Authorization
	  	 	1	  
	            1.2	  	 Sale and Issuance of Shares
	  	 	1	  
		
	SECTION 2 CLOSING DATES AND DELIVERY	  	 	1	  
			
	            2.1	  	 Closing
	  	 	1	  
	            2.2	  	 Delivery
	  	 	2	  
	            2.3	  	 Conversion of Notes
	  	 	2	  
		
	SECTION 3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	 	2	  
			
	            3.1	  	 Organization, Good Standing and Qualification
	  	 	2	  
	            3.2	  	 Subsidiaries
	  	 	3	  
	            3.3	  	 Capitalization
	  	 	3	  
	            3.4	  	 Authorization
	  	 	4	  
	            3.5	  	 Financial Statements
	  	 	4	  
	            3.6	  	 Material Contracts
	  	 	4	  
	            3.7	  	 Intellectual Property
	  	 	5	  
	            3.8	  	 Proprietary Information and Invention Assignment
	  	 	5	  
	            3.9	  	 Title to Properties and Assets; Liens
	  	 	5	  
	            3.10	  	 Compliance with Other Instruments
	  	 	6	  
	            3.11	  	 Litigation
	  	 	6	  
	            3.12	  	 Governmental Consent
	  	 	6	  
	            3.13	  	 Permits
	  	 	6	  
	            3.14	  	 Offering
	  	 	6	  
	            3.15	  	 Registration and Voting Rights
	  	 	7	  
	            3.16	  	 Brokers or Finders
	  	 	7	  
	            3.17	  	 Qualified Small Business Stock
	  	 	7	  
	            3.18	  	 Tax Returns and Payments
	  	 	7	  
	            3.19	  	 Employees
	  	 	7	  
	            3.20	  	 Employee Benefit Plans
	  	 	7	  
		
	SECTION 4 REPRESENTATIONS AND WARRANTIES OF THE INVESTORS	  	 	9	  
			
	            4.1	  	 No Registration
	  	 	9	  
	            4.2	  	 Investment Intent
	  	 	9	  
	            4.3	  	 Investment Experience
	  	 	9	  
	            4.4	  	 Speculative Nature of Investment
	  	 	9	  
	            4.5	  	 Access to Data
	  	 	9	  
	            4.6	  	 Accredited Investor
	  	 	10	  
	            4.7	  	 Residency
	  	 	10	  
	            4.8	  	 Rule 144
	  	 	10	  
	            4.9	  	 No Public Market
	  	 	10	  
	            4.10	  	 Authorization
	  	 	10	  
	            4.11	  	 Brokers or Finders
	  	 	11	  
	            4.12	  	 Tax Advisors
	  	 	11	  
	            4.13	  	 Legends
	  	 	11	  

  
 -i- 

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	SECTION 5 CONDITIONS TO INVESTORS’ OBLIGATIONS TO CLOSE	  	 	11	  
			
	            5.1	  	 Representations and Warranties
	  	 	11	  
	            5.2	  	 Covenants
	  	 	12	  
	            5.3	  	 Blue Sky
	  	 	12	  
	            5.4	  	 Restated Certificate
	  	 	12	  
	            5.5	  	 Rights Agreement
	  	 	12	  
	            5.6	  	 Voting Agreement
	  	 	12	  
	            5.7	  	 Right of First Refusal and Co-Sale Agreement
	  	 	12	  
	            5.8	  	 Closing Deliverables
	  	 	12	  
		
	SECTION 6 CONDITIONS TO COMPANY’S OBLIGATION TO CLOSE	  	 	12	  
			
	            6.1	  	 Representations and Warranties
	  	 	12	  
	            6.2	  	 Covenants
	  	 	13	  
	            6.3	  	 Compliance with Securities Laws
	  	 	13	  
	            6.4	  	 Restated Certificate
	  	 	13	  
	            6.5	  	 Rights Agreement
	  	 	13	  
	            6.6	  	 Voting Agreement
	  	 	13	  
	            6.7	  	 Right of First Refusal and Co-Sale Agreement
	  	 	13	  
		
	SECTION 7 MISCELLANEOUS	  	 	13	  
			
	            7.1	  	 Amendment
	  	 	13	  
	            7.2	  	 Notices
	  	 	13	  
	            7.3	  	 Governing Law
	  	 	14	  
	            7.4	  	 Brokers or Finders
	  	 	14	  
	            7.5	  	 Expenses
	  	 	15	  
	            7.6	  	 Survival
	  	 	15	  
	            7.7	  	 Successors and Assigns
	  	 	15	  
	            7.8	  	 Entire Agreement
	  	 	15	  
	            7.9	  	 Delays or Omissions
	  	 	15	  
	            7.10	  	 California Corporate Securities Law
	  	 	15	  
	            7.11	  	 Indemnification
	  	 	16	  
	            7.12	  	 Severability
	  	 	16	  
	            7.13	  	 Counterparts
	  	 	16	  
	            7.14	  	 Telecopy Execution and Delivery
	  	 	16	  
	            7.15	  	 Further Assurances
	  	 	17	  
	            7.16	  	 Exculpation Among Investors
	  	 	17	  
	            7.17	  	 Rights of Investors
	  	 	17	  
	            7.18	  	 No Commitment for Additional Financing
	  	 	17	  
	            7.19	  	 Waiver of Potential Conflicts of Interest
	  	 	17	  

  
 -ii- 

 EXHIBITS 
  

	A	Schedule of Investors 

	B	Amended and Restated Certificate of Incorporation 

	C	Amended and Restated Investor Rights Agreement 

	D	Amended and Restated Voting Agreement 

	E	Amended and Restated Right of First Refusal and Co-Sale Agreement 

	F	Schedule of Exceptions 

	G	Compliance Certificate 

	H	Secretary’s Certificate 

	I	Opinion of Counsel to the Company 

  
 -iii- 

 UPLAND SOFTWARE, INC. 

SERIES C PREFERRED STOCK PURCHASE AGREEMENT 

This Series C Preferred Stock Purchase Agreement (this “Agreement”) is dated as of December 20, 2013, and is
among Upland Software, Inc. (f/k/a Silverback Enterprise Group, Inc.), a Delaware corporation (the “Company”), and the persons and entities (each, an “Investor” and collectively, the
“Investors”) listed on the Schedule of Investors attached as Exhibit A (the “Schedule of Investors”). 

SECTION 1

AUTHORIZATION, SALE AND ISSUANCE 

1.1 Authorization. 
 The
Company will, prior to the Initial Closing (as defined below), authorize (a) the sale and issuance of up to 11,700,000 shares (the “Shares”) of the Company’s Series C Preferred Stock, par value $0.0001 per
share (the “Series C Preferred”), having the rights, privileges, preferences and restrictions set forth in the amended and restated certificate of incorporation of the Company, in substantially the form of Exhibit B (the
“Restated Certificate”) and (b) the reservation of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) for issuance upon conversion of the Shares (the
“Conversion Shares”). 
 1.2 Sale and Issuance of Shares. Subject to the terms and conditions of this
Agreement, each Investor agrees, severally and not jointly, to purchase, and the Company agrees to sell and issue to each Investor, the number of Shares set forth in the column designated “Number of Series C Shares” opposite such
Investor’s name on the Schedule of Investors, at a purchase price of $1.80 per share (the “Purchase Price”). The Company’s agreement with each Investor is a separate agreement, and the sale and issuance of the
Shares to each Investor is a separate sale and issuance. 
 SECTION 2 
 

CLOSING DATES AND DELIVERY 

2.1 Closing.
 (a) The
purchase, sale and issuance of the Shares shall take place at one or more closings (each of which is referred to in this Agreement as a “Closing”). The initial Closing (the “Initial Closing”) shall
take place at the offices of Wilson Sonsini Goodrich & Rosati, Professional Corporation, 900 South Capital of Texas Highway, Las Cimas IV, Fifth Floor, Austin, Texas 78746-5546, at 10:00 a.m. local time on December 20, 2013, or
such other date as the Company and the Investors participating in the Initial Closing shall agree. 
 (b) If less than all of the Shares are
sold and issued at the Initial Closing, then, subject to the terms and conditions of this Agreement, the Company may sell and issue at one or more subsequent closings (each, a “Subsequent Closing”), within 120 days after the
Initial Closing, up to the balance of the unissued Shares to such persons or entities as may be approved by the Company and 

 
Investors representing a majority of the Shares issued to Investors in previous Closings. Any such sale and issuance in a Subsequent Closing shall be on the same terms and conditions as those
contained herein, and such persons or entities shall, upon execution and delivery of the relevant signature pages, become parties to, and be bound by, this Agreement, the Amended and Restated Investors’ Rights Agreement in substantially the
form of Exhibit C (the “Rights Agreement”), the Amended and Restated Voting Agreement in substantially the form of Exhibit D (the “Voting Agreement”), and the Amended and Restated Right of First
Refusal and Co-Sale Agreement in substantially the form of Exhibit E (the “Right of First Refusal and Co-Sale Agreement,” and together with this Agreement, the Voting Agreement and the Rights Agreement, the
“Agreements”), without the need for an amendment to any of the Agreements except to add such person’s or entity’s name to the appropriate exhibit to such Agreements, and shall have the rights and obligations
hereunder and thereunder, in each case as of the date of the applicable Subsequent Closing. Each Subsequent Closing shall take place at such date, time and place as shall be approved by the Company and the Investors participating in such Subsequent
Closing. 
 (c) Immediately after each Closing, the Schedule of Investors will be amended to list the Investors purchasing Shares hereunder
and the number of Shares issued to each Investor hereunder at each such Closing. The Company will furnish to each Investor copies of the amendments to the Schedule of Investors referred to in the preceding sentence. 

2.2 Delivery. At each Closing, the Company will deliver to each Investor in such Closing a certificate registered in such
Investor’s name representing the number of Shares that such Investor is purchasing in such Closing against payment of the Purchase Price therefor as set forth in the column designated “Purchase Price” opposite such Investor’s
name on the Schedule of Investors, by (a) check payable to the Company, (b) wire transfer in accordance with the Company’s instructions, (c) cancellation or conversion of indebtedness or (d) any combination of the foregoing.
In the event that payment by an Investor is made, in whole or in part, by cancellation or conversion of indebtedness, then such Investor shall surrender to the Company for cancellation at the Closing any evidence of such indebtedness or shall
execute an instrument of cancellation with respect thereto in form and substance acceptable to the Company. 
 2.3 Conversion of
Notes. Each Investor that is a holder of one or more promissory notes listed on the Schedule of Investors (each, a “Note”), hereby acknowledges and agrees by such Investor’s execution of this Agreement that,
effective upon the Closing, all outstanding principal and interest accrued under each Note held by such Investor shall automatically convert into Shares at the price set forth on the Schedule of Investors with respect to such Note, which conversion
shall be deemed to be payment of all or a portion of the purchase price for the Shares as set forth on the Schedule of Investors, and that the issuance of such Shares shall be in full satisfaction and termination of the Company’s obligations
under such Note. 
 SECTION 3

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

A Schedule of Exceptions, attached as Exhibit F (each, a “Schedule of Exceptions”) shall be delivered to the Investors
in connection with each Closing. Except as set forth on the Schedule of Exceptions delivered to the Investor at the applicable Closing, the Company hereby represents and warrants to the Investors as follows: 

3.1 Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good
standing under the laws of the State of Delaware. The Company has the requisite corporate power and authority to own and operate its properties and assets, to carry on its business as presently conducted or proposed to be conducted, to execute and
deliver 

  
 -2- 

 
the Agreements, to issue and sell the Shares and the Conversion Shares and to perform its obligations pursuant to the Agreements and the Restated Certificate. The Company is presently qualified
to do business as a foreign corporation in each jurisdiction where the failure to be so qualified could reasonably be expected to have a material adverse effect on the Company’s financial condition or business as now conducted or proposed to be
conducted (a “Material Adverse Effect”). 
 3.2 Subsidiaries. The Company does not own or control,
directly or indirectly, any interest in any corporation, partnership, limited liability company, association or other business entity. 

3.3 Capitalization.
 (a)
Immediately prior to the Initial Closing, the authorized capital stock of the Company will consist of 74,325,000 shares of Common Stock, of which 11,291,210 shares are issued and outstanding and 56,722,800 shares of Preferred Stock,
18,240,300 of which are designated Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred”), 17,206,508 of which are issued and outstanding, 10,782,500 of which are designated Series B
Preferred Stock, par value $0.0001 per share (the “Series B Preferred”), 10,380,000 of which are issued and outstanding, 6,000,000 of which are designated Series B-1 Preferred Stock, par value $0.0001 per share (the
“Series B-1 Preferred”), 1,450,000 of which are issued and outstanding, 10,000,000 of which are designated Series B-2 Preferred Stock, par value $0.0001 per share (the “Series B-2
Preferred”), 949,000 of which are issued and outstanding, and 11,700,000 of which are designated Series C Preferred, none of which are issued and outstanding. The Common Stock, the Series A Preferred, the Series B Preferred,
the Series B-1 Preferred, the Series B-2 Preferred and the Series C Preferred shall have the rights, preferences, privileges and restrictions set forth in the Restated Certificate. 

(b) The outstanding shares have been duly authorized and validly issued in compliance with applicable laws, and are fully paid and
nonassessable. 
 (c) The Company has reserved: 

(i) the Shares for issuance pursuant to this Agreement; 

(ii) 11,700,000 shares of Common Stock (as may be adjusted in accordance with the provisions of the Restated Certificate) for issuance upon
conversion of the Shares; 
 (iii) 18,240,300 shares of Common Stock (as may be adjusted in accordance with the provisions of the Restated
Certificate) for issuance upon conversion of the Series A Preferred; 
 (iv) 10,782,500 shares of Common Stock (as may be adjusted in
accordance with the provisions of the Restated Certificate) for issuance upon conversion of the Series B Preferred; 
 (v) 1,450,000
shares of Common Stock (as may be adjusted in accordance with the provisions of the Restated Certificate) for issuance upon conversion of the Series B-1 Preferred; 

(vi) 949,000 shares of Common Stock (as may be adjusted in accordance with the provisions of the Restated Certificate) for issuance upon
conversion of the Series B-2 Preferred; 
 (vii) 5,777,992 shares of Common Stock authorized for issuance to employees,
consultants and directors pursuant to its Amended and Restated 2010 Equity Incentive Plan, under which 2,455,096 options to purchase shares are issued and outstanding as of the date of this Agreement. 

  
 -3- 

 (d) The Shares, when issued and delivered and paid for in compliance with the provisions of this
Agreement, will be validly issued, fully paid and nonassessable. The Conversion Shares have been duly and validly reserved and, when issued in compliance with the provisions of this Agreement, the Restated Certificate and applicable law, will be
validly issued, fully paid and nonassessable. The Shares and the Conversion Shares will be free of any liens or encumbrances, other than any liens or encumbrances created by or imposed upon the Investors; provided, however, that the Shares
and the Conversion Shares are subject to restrictions on transfer under U.S. state and/or federal securities laws and as set forth herein and in the Rights Agreement. Except as set forth in the Rights Agreement, the Shares and the Conversion Shares
are not subject to any preemptive rights or rights of first refusal. 
 (e) Except for the conversion privileges of the Series A
Preferred, Series B Preferred, Series B-1 Preferred, Series B-2 Preferred and Series C Preferred, the rights provided pursuant to the Rights Agreement and the Right of First Refusal and Co-Sale Agreement or as otherwise described in this
Agreement, there are no outstanding options, warrants or other rights to purchase any of the Company’s authorized and unissued capital stock. 

3.4 Authorization. All corporate action on the part of the Company and its directors, officers and stockholders necessary for the
authorization, execution and delivery of the Agreements by the Company, the authorization, sale, issuance and delivery of the Shares and the Conversion Shares, and the performance of all of the Company’s obligations under the Agreements has
been taken or will be taken prior to the Initial Closing. The Agreements, when executed and delivered by the Company, shall constitute valid and binding obligations of the Company, enforceable in accordance with their terms, except (i) as
limited by laws of general application relating to bankruptcy, insolvency and the relief of debtors, (ii) as limited by rules of law governing specific performance, injunctive relief or other equitable remedies and by general principles of
equity, and (iii) to the extent the indemnification provisions contained in the Rights Agreement may further be limited by applicable laws and principles of public policy. 

3.5 Financial Statements. The Company has delivered to each Investor its audited financial statements for the fiscal years ended
December 31, 2011 and December 31, 2012, and its unaudited financial statements (including balance sheet, income statement and statement of cash flows) for the three-month periods ended
March 31, 2013, June 30, 2013, and September 30, 2013 (collectively, the “Financial Statements”). The Financial Statements have been prepared in accordance with generally accepted accounting principles
applied on a consistent basis throughout the periods indicated, except that unaudited Financial Statements may not contain all footnotes required by generally accepted accounting principles. The Financial Statements fairly present in all material
respects the financial condition and operating results of the Company as of the dates, and for the periods, indicated therein, subject in the case of the unaudited Financial Statements to normal year-end audit
adjustments and further subject to interim adjustments to prior purchase accounting estimates. Except as set forth in the Financial Statements, the Company has no material liabilities or obligations, contingent or otherwise, other than
(i) liabilities incurred in the ordinary course of business subsequent to September 30, 2013, (ii) obligations under contracts and commitments incurred in the ordinary course of business, (iii) liabilities and obligations of a
type or nature not required under generally accepted accounting principles to be reflected in the Financial Statements, and (iv) liabilities incurred subsequent to September 30, 2013 as a result of the Company’s acquisition of ComSci
Solutions, LLC, which, in all such cases, individually and in the aggregate would not have a Material Adverse Effect. The Company maintains and will continue to maintain a standard system of accounting established and administered in accordance with
generally accepted accounting principles. 
 3.6 Material Contracts. Except for the agreements explicitly contemplated hereby,
there are no agreements, understandings, instruments, contracts, transactions, judgments, orders, writs or decrees to which the Company is a party, or by which it is bound which may involve (i) obligations of, or payments to, the Company in
excess of $50,000 (other than obligations of, or payments to, the Company arising from purchase or sale agreements entered into in the ordinary course of business), or (ii) the license of any patent, copyright, trade secret or other proprietary
right to or from the Company (each, a “Material Contract,” collectively the “Material Contracts”). To the Company’s knowledge, all of the Material Contracts are valid, binding and in full force
and effect in all material respects, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other equitable remedies and to general
principles of equity. The Company is not in material default under any of such Material Contracts. 

  
 -4- 

 3.7 Intellectual Property.

(a) Ownership. To the knowledge of the Company, it owns or possesses sufficient legal rights to all patents, trademarks, service
marks, trade names, copyrights, trade secrets, licenses (software or otherwise), information, processes and similar proprietary rights (“Intellectual Property”) necessary to the business of the Company as presently conducted,
the lack of which could reasonably be expected to have a Material Adverse Effect without any conflict with or infringement of the rights of others. Except for agreements with its own employees or consultants, standard end-user license agreements,
support/maintenance agreements and agreements entered in the ordinary course of the Company’s business, there are no outstanding options, licenses or agreements relating to the Intellectual Property, and the Company is not bound by or a party
to any options, licenses or agreements with respect to the Intellectual Property of any other person or entity. To the knowledge of the Company, it has not violated nor, to the knowledge of the Company, by conducting its business as currently
conducted, would it violate any of the Intellectual Property of any other person or entity, nor has the Company received any written communication alleging such a violation. 

(b) No Breach by Employees. The Company is not aware that any of its employees is obligated under any contract or other
agreement, or subject to any judgment, decree or order of any court or administrative agency, that would materially interfere with the use of his or her efforts to promote the interests of the Company or that would conflict with the Company’s
business as presently conducted. Neither the execution nor delivery of this Agreement, nor the carrying on of the Company’s business by the employees of the Company, nor the conduct of the Company’s business as presently conducted, will,
to the Company’s knowledge, conflict with or result in a breach of the terms, conditions or provisions of, or constitute a default under, any contract, covenant or instrument under which any of such employees is now obligated. The Company does
not believe it is or will be necessary to use any inventions of any of its employees made prior to their employment by the Company. 

3.8 Proprietary Information and Invention Assignment. Each current and former employee of the Company has executed a confidential
information and invention assignment agreement in the form attached to the Schedule of Exceptions. Each consultant to the Company that has had access to the Company’s Intellectual Property has entered into an agreement containing appropriate
confidentiality and invention assignment provisions. To the knowledge of the Company, no officer, employee or consultant of the Company is in violation of such confidential information and invention assignment agreement or any prior employee
contract or proprietary information agreement with any other corporation or third party 
 3.9 Title to Properties and Assets;
Liens. The Company has good and marketable title to its properties and assets, and has good title to all its leasehold interests, in each case subject to no material mortgage, pledge, lien, lease, encumbrance or charge, other than
(i) liens for current taxes not yet due and payable, (ii) liens imposed by law and incurred in the ordinary course of business for obligations not past due, (iii) liens in respect of pledges or deposits under workers’
compensation laws or similar legislation, and 
 (iv) liens, encumbrances and defects in title which do not in any case materially detract from the
value of the property subject thereto or have a Material Adverse Effect, and which have not arisen otherwise than in the ordinary course of business. With respect to the property and assets it leases, the Company is in compliance with such leases in
all material respects and, to its knowledge, holds a valid leasehold interest free of any liens, claims or encumbrances, subject to clauses (i)-(iv) above. 

  
 -5- 

 3.10 Compliance with Other Instruments.

(a) The Company is not in violation of any material term of its certificate of incorporation or bylaws, each as amended to date, or, to the
Company’s knowledge, in any material respect of any term or provision of any mortgage, indebtedness, indenture, contract, agreement, instrument, judgment, order or decree to which it is party or by which it is bound which would have a Material
Adverse Effect. To the Company’s knowledge, the Company is not in violation of any federal or state statute, rule or regulation applicable to the Company the violation of which would have a Material Adverse Effect. The execution and delivery of
the Agreements by the Company, the performance by the Company of its obligations pursuant to the Agreements, and the issuance of the Shares, and the Conversion Shares, will not result in any material violation of, or materially conflict with, or
constitute a material default under, the Company’s certificate of incorporation or bylaws, each as amended to date, or any of its agreements, nor, to the Company’s knowledge, result in the creation of any mortgage, pledge, lien,
encumbrance or charge upon any of the properties or assets of the Company or the suspension, revocation, impairment, forfeiture or nonrenewal of any permit, license, authorization or approval applicable to the Company, its business or operations or
any of its assets or properties. 
 3.11 Litigation. There are no actions, suits, proceedings or investigations pending against
the Company or its properties (nor has the Company received written notice of any threat thereof) before any court or governmental agency. To the Company’s knowledge, there is no legitimate basis for or threat of an action, suit, proceeding, or
investigation against the Company that could reasonably be expected to have a Material Adverse Effect. The Company is not a party or subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or
instrumentality. There is no action, suit, proceeding, or investigation by the Company currently pending or that the Company currently intends to initiate. 

3.12 Governmental Consent. No consent, approval or authorization of or designation, declaration or filing with any governmental
authority on the part of the Company is required in connection with the valid execution and delivery of this Agreement, or the offer, sale or issuance of the Shares and the Conversion Shares, or the consummation of any other transaction contemplated
by this Agreement, except (i) filing of the Restated Certificate with the office of the Secretary of State of the State of Delaware, (ii) the filing of such notices as may be required under the Securities Act of 1933, as amended (the
“Securities Act”) and (iii) such filings as may be required under applicable state securities laws. 
 3.13
Permits. The Company has all franchises, permits, licenses, and any similar authority necessary for the conduct of its business as now being conducted by it, the lack of which would have a Material Adverse Effect, and believes it can
obtain, without undue burden or expense, any similar authority for the conduct of its business as presently planned to be conducted. The Company is not in default in any material respect under any of such franchises, permits, licenses or other
similar authority. 
 3.14 Offering. Subject to the accuracy of the Investors’ representations and warranties in
Section 4, the offer, sale and issuance of the Shares to be issued in conformity with the terms of this Agreement and the issuance of the Conversion Shares, constitute transactions exempt from the registration requirements of Section 5 of
the Securities Act. 

  
 -6- 

 3.15 Registration and Voting Rights. Except as set forth in the Rights Agreement, the
Company is presently not under any obligation and has not granted any rights to register under the Securities Act any of its presently outstanding securities or any of its securities that may hereafter be issued. To the Company’s knowledge,
except as contemplated in the Voting Agreement, no stockholder of the Company has entered into any agreements with respect to the voting of capital shares of the Company. 

3.16 Brokers or Finders. The Company has not incurred, and will not incur, directly or indirectly, as a result of any action taken
by the Company, any liability for brokerage or finders’ fees or agents’ commissions or any similar charges in connection with this Agreement or any of the transactions contemplated hereby. 

3.17 Qualified Small Business Stock. As of the date of this Agreement, the Shares constitute “qualified small business
stock” within the meaning of Section 1202 of the Internal Revenue Code of 1986, as amended. 
 3.18 Tax Returns and
Payments. The Company has timely filed all tax returns required to be filed by it with appropriate federal, state and local governmental agencies, except where the failure to do so would not have a Material Adverse Effect. These returns and
reports are true and correct in all material respects. All taxes shown to be due and payable on such returns, any assessments imposed, and, to the Company’s knowledge, all other taxes due and payable by the Company have been paid or will be
paid prior to the time they become delinquent. 
 3.19 Employees. There are no strike, labor dispute or union organization
activities pending or threatened between it and its employees. To the Company’s knowledge, none of its employees belongs to any union or collective bargaining unit. The Company is not a party to or bound by any currently effective employment
contract, deferred compensation agreement, bonus plan, incentive plan, profit sharing plan, retirement agreement, or other employee compensation agreement. The Company is not aware that any officer or key employee intends to terminate his employment
with the Company, nor does the Company have a present intention to terminate the employment of any officer or key employee. Subject to general principles related to wrongful termination of employees, the employment of each officer and employee of
the Company is terminable at the will of the Company. 
 3.20 Employee Benefit Plans. The Company is in substantial compliance
with its “employee benefit plans” as defined in the Employee Retirement Income Security Act of 1974, as amended. 
 3.21
Changes. Since September 30, 2013, there has not been: 
 (a) any change in the assets, liabilities, financial condition or
operating results of the Company from that reflected in the Financial Statements, except changes in the ordinary course of business that have not caused, in the aggregate, a Material Adverse Effect; 

(b) any damage, destruction or loss, whether or not covered by insurance, that would have a Material Adverse Effect; 

(c) any waiver or compromise by the Company of a valuable right or of a material debt owed to it; 

(d) any satisfaction or discharge of any lien, claim, or encumbrance or payment of any obligation by the Company, except in the ordinary course
of business and the satisfaction or discharge of which would not have a Material Adverse Effect; 

  
 -7- 

 (e) any material change to a material contract or agreement by which the Company or any of its
assets is bound or subject; 
 (f) any material change in any compensation arrangement or agreement with any employee, officer, director or
stockholder; 
 (g) any resignation or termination of employment of any officer or key employee of the Company; 

(h) any mortgage, pledge, transfer of a security interest in, or lien, created by the Company, with respect to any of its material properties
or assets, except liens for taxes not yet due or payable and liens that arise in the ordinary course of business and do not materially impair the Company’s ownership or use of such property or assets; 

(i) any loans or guarantees made by the Company to or for the benefit of its employees, officers or directors, or any members of their
immediate families, other than travel advances and other advances made in the ordinary course of its business; 
 (j) any declaration,
setting aside or payment or other distribution in respect of any of the Company’s capital stock, or any direct or indirect redemption, purchase, or other acquisition of any of such stock by the Company; 

(k) any sale, assignment or transfer of any Company Intellectual Property that could reasonably be expected to result in a Material Adverse
Effect; 
 (l) receipt of notice that there has been a loss of, or material order cancellation by, any major customer of the Company; 

(m) to the Company’s knowledge, any other event or condition of any character, other than events affecting the economy or the
Company’s industry generally, that could reasonably be expected to result in a Material Adverse Effect; or 
 (n) any arrangement or
commitment by the Company to do any of the things described in this Section 3.21. 
 3.23 Obligations to Related Parties 

No employee, officer, director or, to the Company’s knowledge, stockholder of the Company or member of his or her immediate family is
indebted to the Company, nor is the Company indebted (or committed to make loans or extend or guarantee credit) to any of them other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred
on behalf of the Company and (iii) for other standard employee benefits made generally available to all employees (including stock option agreements outstanding under any stock option plan approved by the Company’s Board of Directors and
stock purchase agreements approved by the Company’s Board of Directors). To the Company’s knowledge, none of such persons has any direct or indirect ownership interest in any firm or corporation with which the Company is affiliated or with
which the Company has a business relationship, or any firm or corporation that competes with the Company, except in connection with the ownership of stock in publicly-traded companies or in connection with such person’s ownership of Nighthawk
Acquisition Corporation, Silverback Enterprise Group, Inc. or Visonael Software, Inc. To the Company’s knowledge, no employee, officer, director or stockholder, nor any member of their immediate families, is, directly or indirectly, interested
in any material contract with the Company (other than such contracts as relate to any such person’s ownership of capital stock or other securities of the Company). 

  
 -8- 

 SECTION 4

REPRESENTATIONS AND WARRANTIES OF THE INVESTORS 

Each Investor hereby, severally and not jointly, represents and warrants to the Company as follows: 

4.1 No Registration. The Investor understands that the Shares and the Conversion Shares, have not been, and will not be,
registered under the Securities Act by reason of a specific exemption from the registration provisions of the Securities Act, the availability of which depends upon, among other things, the bona fide nature of the investment intent and the accuracy
of the Investor’s representations as expressed herein or otherwise made pursuant hereto. 
 4.2 Investment Intent. The
Investor is acquiring the Shares, and the Conversion Shares, for investment for its own account, not as a nominee or agent, and not with the view to, or for resale in connection with, any distribution thereof, and that the Investor has no present
intention of selling, granting any participation in, or otherwise distributing the same. The Investor further represents that it does not have any contract, undertaking, agreement or arrangement with any person or entity to sell, transfer or grant
participation to such person or entity or to any third person or entity with respect to any of the Shares or the Conversion Shares. 

4.3 Investment Experience. The Investor, has substantial experience in evaluating and investing in private placement transactions
of securities in companies similar to the Company and acknowledges that the Investor, can protect its own interests. The Investor has such knowledge and experience in financial and business matters so that the Investor is capable of evaluating the
merits and risks of its investment in the Company. 
 4.4 Speculative Nature of Investment. The Investor understands and
acknowledges that the Company has a limited financial and operating history and that an investment in the Company is highly speculative and involves substantial risks. The Investor can bear the economic risk of the Investor’s investment and is
able, without impairing the Investor’s financial condition, to hold the Shares and the Conversion Shares for an indefinite period of time and to suffer a complete loss of the Investor’s investment. 

4.5 Access to Data. The Investor has had an opportunity to ask questions of, and receive answers from, the officers of the Company
concerning the Agreements, the exhibits and schedules attached hereto and thereto and the transactions contemplated by the Agreements, as well as the Company’s business, management and financial affairs, which questions were answered to its
satisfaction. The Investor believes that it has received all the information the Investor considers necessary or appropriate for deciding whether to purchase the Shares and the Conversion Shares. The Investor understands that such discussions, as
well as any information issued by the Company, were intended to describe certain aspects of the Company’s business and prospects, but were not necessarily a thorough or exhaustive description. The Investor acknowledges that any business plans
prepared by the Company have been, and continue to be, subject to change and that any projections included in such business plans or otherwise are necessarily speculative in nature, and it can be expected that some or all of the assumptions
underlying the projections will not materialize or will vary significantly from actual results. The Investor also acknowledges that it is relying solely on its own counsel and not on any statements or representations of the Company or its agents for
legal advice with respect to this investment or the transactions contemplated by the Agreements. The foregoing, however, does not limit or modify the representations and warranties of the Company in Section 3 of this Agreement or the right of
the Investor to rely thereon. 

  
 -9- 

 4.6 Accredited Investor. The Investor is an “accredited investor” within
the meaning of Regulation D, Rule 501(a), promulgated by the Securities and Exchange Commission under the Securities Act and shall submit to the Company such further assurances of such status as may be reasonably requested by the Company. 

4.7 Residency. The residency of the Investor (or, in the case of a partnership or corporation, such entity’s principal place
of business) is correctly set forth on the Schedule of Investors. 
 4.8 Rule 144. The Investor acknowledges that the Shares and
the Conversion Shares must be held indefinitely unless subsequently registered under the Securities Act or an exemption from such registration is available. The Investor is aware of the provisions of Rule 144 promulgated under the Securities Act
which permit resale of shares purchased in a private placement subject to the satisfaction of certain conditions, which may include, among other things, the availability of certain current public information about the Company; the resale occurring
not less than a specified period after a party has purchased and paid for the security to be sold; the number of shares being sold during any three-month period not exceeding specified limitations; the sale being effected through a
“brokers’ transaction,” a transaction directly with a “market maker” or a “riskless principal transaction” (as those terms are defined in the Securities Act or the Securities Exchange Act of 1934, as amended, and
the rules and regulations promulgated thereunder); and the filing of a Form 144 notice, if applicable. The Investor understands that the current public information referred to above is not now available and the Company has no present plans to
make such information available. The Investor acknowledges and understands that notwithstanding any obligation under the Rights Agreement, the Company may not be satisfying the current public information requirement of Rule 144 at the time the
Investor wishes to sell the Shares or the Conversion Shares, and that, in such event, the Investor may be precluded from selling such securities under Rule 144, even if the other applicable requirements of Rule 144 have been satisfied. The Investor
acknowledges that, in the event the applicable requirements of Rule 144 are not met, registration under the Securities Act or an exemption from registration will be required for any disposition of the Shares or the underlying Common Stock. The
Investor understands that, although Rule 144 is not exclusive, the Securities and Exchange Commission has expressed its opinion that persons proposing to sell restricted securities received in a private offering other than in a registered offering
or pursuant to Rule 144 will have a substantial burden of proof in establishing that an exemption from registration is available for such offers or sales and that such persons and the brokers who participate in the transactions do so at their own
risk. 
 4.9 No Public Market. The Investor understands and acknowledges that no public market now exists for any of the
securities issued by the Company and that the Company has made no assurances that a public market will ever exist for the Company’s securities. 

4.10 Authorization.
 (a)
The Investor has all requisite power and authority to execute and deliver the Agreements, to purchase the Shares hereunder and to carry out and perform its obligations under the terms of the Agreements. All action on the part of the Investor
necessary for the authorization, execution, delivery and performance of the Agreements, and the performance of all of the Investor’s obligations under the Agreements, has been taken or will be taken prior to the Closing. 

  
 -10- 

 (b) The Agreements, when executed and delivered by the Investor, will constitute valid and
legally binding obligations of the Investor, enforceable in accordance with their terms except: (i) to the extent that the indemnification provisions contained in the Rights Agreement may be limited by applicable law and principles of public
policy, (ii) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, and (iii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies or by general principles of equity. 
 (c) No consent,
approval, authorization, order, filing, registration or qualification of or with any court, governmental authority or third person is required to be obtained by the Investor in connection with the execution and delivery of the Agreements by the
Investor or the performance of the Investor’s obligations hereunder or thereunder. 
 4.11 Brokers or Finders. The Investor
has not engaged any brokers, finders or agents, and neither the Company nor any other Investor has, nor will, incur, directly or indirectly, as a result of any action taken by the Investor, any liability for brokerage or finders’ fees or
agents’ commissions or any similar charges in connection with the Agreements. 
 4.12 Tax Advisors. The Investor has
reviewed with its own tax advisors the U.S. federal, state, local and foreign tax consequences of this investment and the transactions contemplated by the Agreements. With respect to such matters, the Investor relies solely on such advisors and not
on any statements or representations of the Company or any of its agents, written or oral. The Investor understands that it (and not the Company) shall be responsible for its own tax liability that may arise as a result of this investment or the
transactions contemplated by the Agreements. 
 4.13 Legends. The Investor understands and agrees that the certificates
evidencing the Shares or the Conversion Shares, or any other securities issued in respect of the Shares or the Conversion Shares upon any stock split, stock dividend, recapitalization, merger, consolidation or similar event, shall bear the following
legend (in addition to any legend required by the Rights Agreement or under applicable state securities laws): 
 “THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SUCH
ACT AND/OR APPLICABLE STATE SECURITIES LAWS, OR UNLESS THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.” 

SECTION 5

CONDITIONS TO INVESTORS’ OBLIGATIONS TO CLOSE 

Each Investor’s obligation to purchase the Shares at a Closing is subject to the fulfillment on or before the Closing of each of the
following conditions, unless waived by the applicable Investor purchasing the Shares in such Closing: 
 5.1 Representations and
Warranties. Except as set forth in or modified by the Schedule of Exceptions, the representations and warranties made by the Company in Section 3 shall be true and correct in all material respects as of the date of such Closing. 

  
 -11- 

 5.2 Covenants. The Company shall have performed or complied with all covenants,
agreements and conditions contained in this Agreement to be performed or complied with by the Company on or prior to such Closing in all material respects. 

5.3 Blue Sky. The Company shall have obtained all necessary Blue Sky law permits and qualifications, or have the availability of
exemptions therefrom, required by any state for the offer and sale of the Shares and the Conversion Shares. 
 5.4 Restated
Certificate. The Restated Certificate shall have been duly authorized, executed and filed with and accepted by the Secretary of State of the State of Delaware. 

5.5 Rights Agreement. The Company and the Investors (each as defined in the Rights Agreement) shall have executed and delivered
the Rights Agreement. 
 5.6 Voting Agreement. The Company, the Founders and the Investors (each as defined in the Voting
Agreement) shall have executed and delivered the Voting Agreement. 
 5.7 Right of First Refusal and Co-Sale Agreement. The
Company, the Founders and the Investors (each as defined in the Right of First Refusal and Co-Sale Agreement) shall have executed and delivered the Right of First Refusal and Co-Sale Agreement. 

5.8 Closing Deliverables. The Company shall have delivered to counsel to the Investors the following: 

(a) a certificate executed by the Chief Executive Officer, President or Chief Financial Officer of the Company on behalf of the Company, in
substantially the form of Exhibit G, certifying the satisfaction of the conditions to closing listed in Sections 5.1 and 5.2; 
 (b) a
certificate of the Secretary of State of the State of Delaware, dated as of a date within five days of the date of the Initial Closing, with respect to the good standing of the Company; 

(c) a certificate of the Company executed by the Company’s Assistant Secretary, in substantially the form of Exhibit H, attaching and
certifying to the truth and correctness of (1) the Restated Certificate, (2) the bylaws and (3) the board and stockholder resolutions adopted in connection with the transactions contemplated by this Agreement; and 

(d) with respect to the Initial Closing only, an opinion from Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel to
the Company, dated as of the Initial Closing, in substantially the form of Exhibit I. 
 SECTION 6  

CONDITIONS TO COMPANY’S OBLIGATION TO CLOSE 

The Company’s obligation to sell and issue the Shares at each Closing is subject to the fulfillment on or before such Closing of the
following conditions, unless waived by the Company: 
 6.1 Representations and Warranties. The representations and warranties
made by the Investors in such Closing in Section 4 shall be true and correct when made and shall be true and correct as of the date of such Closing. 

  
 -12- 

 6.2 Covenants. The Investors shall have performed or complied with all covenants,
agreements and conditions contained in the Agreements to be performed or complied with by the Investors on or prior to the date of such Closing in all material respects. 

6.3 Compliance with Securities Laws. The Company shall be satisfied that the offer and sale of the Shares and the Conversion
Shares shall be qualified or exempt from registration or qualification under all applicable federal and state securities laws (including receipt by the Company of all necessary blue sky law permits and qualifications required by any state, if any).

 6.4 Restated Certificate. The Restated Certificate shall have been duly authorized, executed and filed with and accepted by
the Secretary of State of the State of Delaware. 
 6.5 Rights Agreement. The Company and the Investors (each as defined in the
Rights Agreement) shall have executed and delivered the Rights Agreement. 
 6.6 Voting Agreement. The Company, the Founders and
the Investors (each as defined in the Voting Agreement) shall have executed and delivered the Voting Agreement. 
 6.7 Right of First
Refusal and Co-Sale Agreement. The Company, the Founders and the Investors (each as defined in the Right of First Refusal and Co-Sale Agreement) shall have executed and delivered the Right of First Refusal and Co-Sale Agreement. 

SECTION 7 

MISCELLANEOUS 
 7.1
Amendment. Except as expressly provided herein, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written instrument referencing this Agreement and signed by the Company and the
Investors holding a majority of the Common Stock issued or issuable upon conversion of the Shares issued pursuant to this Agreement (excluding any of such shares that have been sold to the public or pursuant to Rule 144); provided, however,
that Investors purchasing shares in a Closing after the Initial Closing may become parties to this Agreement in accordance with Section 2.1 without any amendment of this Agreement pursuant to this paragraph or any consent or approval of any
other Investor. Any such amendment, waiver, discharge or termination effected in accordance with this paragraph shall be binding upon each holder of any securities purchased under this Agreement at the time outstanding (including securities into
which such securities have been converted or exchanged or for which such securities have been exercised) and each future holder of all such securities. Each Investor acknowledges that, except as otherwise set forth herein, by the operation of this
paragraph, the holders of a majority of the Common Stock issued or issuable upon conversion of the Shares issued pursuant to this Agreement (excluding any of such shares that have been sold to the public or pursuant to Rule 144) will have the right
and power to diminish or eliminate all rights of such Investor under this Agreement. 
 7.2 Notices. All notices and other
communications required or permitted hereunder shall be in writing and shall be mailed by registered or certified mail, postage prepaid, sent by facsimile or electronic mail (if to an Investor or any other holder of Company securities) or otherwise
delivered by hand, messenger or courier service addressed: 

  
 -13- 

 (a) if to an Investor, to the Investor’s address, facsimile number or electronic mail
address as shown in the exhibits to this Agreement or in the Company’s records, as may be updated in accordance with the provisions hereof; 

(b) if to any other holder of any Shares or Conversion Shares, to such address, facsimile number or electronic mail address as shown in the
exhibits to this Agreement or in the Company’s records, or, until any such holder so furnishes an address, facsimile number or electronic mail address to the Company, then to the address, facsimile number or electronic mail address of the last
holder of such Shares or Conversion Shares for which the Company has contact information in its records; or 
 (c) if to the Company, to the
attention of the Chief Executive Officer or Chief Financial Officer of the Company at 401 Congress Ave., Suite 2950, Austin, Texas 78701, or at such other current address as the Company shall have furnished to the Investors, with a copy (which shall
not constitute notice) to Brian K. Beard, Wilson Sonsini Goodrich & Rosati, P.C., 900 South Capital of Texas Highway, Las Cimas IV, Fifth Floor, Austin, Texas 78746-5546. 

Each such notice or other communication shall for all purposes of this Agreement be treated as effective or having been given (i) if
delivered by hand, messenger or courier service, when delivered (or if sent via a nationally-recognized overnight courier service, freight prepaid, specifying next-business-day delivery, one business day after deposit with the courier), or
(ii) if sent via mail, at the earlier of its receipt or five days after the same has been deposited in a regularly-maintained receptacle for the deposit of the United States mail, addressed and mailed as aforesaid, or (iii) if sent via
facsimile, upon confirmation of facsimile transfer or, if sent via electronic mail, upon confirmation of delivery when directed to the relevant electronic mail address, if sent during normal business hours of the recipient, or if not sent during
normal business hours of the recipient, then on the recipient’s next business day. In the event of any conflict between the Company’s books and records and this Agreement or any notice delivered hereunder, the Company’s books and
records will control absent fraud or error. 
 Subject to the limitations set forth in Delaware General Corporation Law §232(e), each
Investor or other security holder consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s certificate of incorporation or bylaws by (i) facsimile
telecommunication to the facsimile number set forth on Exhibit A (or to any other facsimile number for the Investor or other security holder in the Company’s records), (ii) electronic mail to the electronic mail address set forth on
Exhibit A (or to any other electronic mail address for the Investor or other security holder in the Company’s records if provided by such Investor), (iii) posting on an electronic network together with separate notice, in accordance with
subsection (i) or (ii), to the Investor or other security holder of such specific posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the Investor or other security
holder. This consent may be revoked by an Investor or other security holder by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law §232. 

7.3 Governing Law. This Agreement shall be governed in all respects by the internal laws of the State of Delaware as applied to
agreements entered into among Delaware residents to be performed entirely within Delaware, without regard to principles of conflicts of law. 

7.4 Brokers or Finders. The Company shall indemnify and hold harmless each Investor from any liability for any commission or
compensation in the nature of a brokerage or finder’s fee or agent’s commission (and the costs and expenses of defending against such liability or asserted liability) for which such Investor or any of its constituent partners, members,
officers, directors, employees or representatives is responsible to the extent such liability is attributable to any inaccuracy or breach of the representations and 

  
 -14- 

 
warranties contained in Section 3.16, and each Investor agrees to indemnify and hold harmless the Company and each other Investor from any liability for any commission or compensation in the
nature of a brokerage or finder’s fee or agent’s commission (and the costs and expenses of defending against such liability or asserted liability) for which the Company, any other Investor or any of their constituent partners, members,
officers, directors, employees or representatives is responsible to the extent such liability is attributable to any inaccuracy or breach of the representations and warranties contained in Section 4.11. 

7.5 Expenses. The Company and the Investors shall each pay their own expenses in connection with the transactions contemplated by
this Agreement; provided, however, that if the Initial Closing is effected, the Company shall reimburse the reasonable documented fees of any legal, accounting, travel and related costs and expenses, such amount not to exceed an aggregate of
$75,000. 
 7.6 Survival. The representations, warranties, covenants and agreements made in this Agreement shall survive any
investigation made by any party hereto and the closing of the transactions contemplated hereby for one year from the date of the Initial Closing. 

7.7 Successors and Assigns. This Agreement, and any and all rights, duties and obligations hereunder, shall not be assigned,
transferred, delegated or sublicensed by any Investor without the prior written consent of the Company; provided, however, that an Investor may transfer or assign Investor’s rights, duties and obligations hereunder without the
Company’s prior written consent in connection with a transfer or assignment effected in accordance with the terms of the Company’s Amended and Restated Right of First Refusal and Co-Sale Agreement and Amended and Restated Investors’
Rights Agreement, so long as the transferee or assignee delivers to the Company an executed joinder whereby such transferee or assignee agrees to become a party to this Agreement. Except as otherwise provided in the foregoing sentence, any attempt
by an Investor without such permission to assign, transfer, delegate or sublicense any rights, duties or obligations that arise under this Agreement shall be void. Subject to the foregoing and except as otherwise provided herein, the provisions of
this Agreement shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

7.8 Entire Agreement. This Agreement, including the exhibits attached hereto, constitute the full and entire understanding and
agreement between the parties with regard to the subjects hereof and thereof. No party shall be liable or bound to any other party in any manner with regard to the subjects hereof or thereof by any warranties, representations or covenants except as
specifically set forth herein or therein. 
 7.9 Delays or Omissions. Except as expressly provided herein, no delay or omission
to exercise any right, power or remedy accruing to any party to this Agreement upon any breach or default of any other party under this Agreement shall impair any such right, power or remedy of such non-defaulting party, nor shall it be construed to
be a waiver of any such breach or default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore
or thereafter occurring. Any waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this
Agreement, must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party to this Agreement, shall be cumulative and not
alternative. 
 7.10 California Corporate Securities Law. THE SALE OF THE SECURITIES THAT ARE THE SUBJECT OF THIS AGREEMENT HAS
NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA AND THE ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL UNLESS THE SALE OF
SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102, OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO
EXEMPT. 
  

  
 -15- 

 7.11 Indemnification. The Company, without limitation as to time, assumes liability
for and agrees to indemnify, defend and hold harmless each Investor and its officers, directors, stockholders, partners, employees, agents and affiliates (collectively, “Indemnified Persons”) from and against, all losses,
claims, damages, liabilities, obligations, fines, penalties, judgments, settlements, costs, expenses and disbursements (including attorneys’ fees and expenses) (collectively, “Losses”) (i) arising out of or related
to any breach or inaccuracy of any representation or warranty of the Company contained in this Agreement; (ii) any non-fulfillment or breach of any covenant or agreement of the Company contained in this Agreement or any of the Agreements; or
(iii) incurred in connection with any action or proceeding against the Company or any Indemnified Person arising out of or in connection with this Agreement, any of the Agreements (or any other document or instrument executed pursuant hereto or
thereto), or the transactions contemplated herein or therein, other than (x) Losses that are finally determined in such action or proceeding to be primarily and directly a result of (I) the gross negligence of such Indemnified Person,
(II) a breach of a fiduciary duty, if any, owed by such Indemnified Person to the Company, (III) the willful misconduct or a knowing violation of applicable law by such Indemnified Person, or (IV) a transaction from which such
Indemnified Person received an improper personal benefit, or (y) Losses that are the subject of the indemnification agreement entered into by the Company and such Indemnified Person pursuant to the Rights Agreement, as to which Losses such
indemnification agreement, rather than this Section 7.11, shall apply. The Company agrees to reimburse each Indemnified Person promptly for all such Losses as they are incurred by such Indemnified Person after the Company receives a written
undertaking of such Indemnified Person to reimburse the Company for any payments made by the Company to such Indemnified Person if it is finally determined in such action or proceeding that such Indemnified Person is not entitled to indemnification
pursuant to clause (iii) above. The obligations of the Company to each Indemnified Person under this Section 7.11 will be separate and distinct obligations and will survive any transfer of securities by any Investor and the expiration or
termination of this Agreement or any of the Agreements. THE COMPANY AND THE INVESTORS INTEND THAT THE INDEMNIFIED PERSONS BE INDEMNIFIED FROM LIABILITY FOR THEIR OWN NEGLIGENCE PURSUANT TO THIS SECTION 7.11. 

7.12 Severability. If any provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal,
unenforceable or void, portions of such provision, or such provision in its entirety, to the extent necessary, shall be severed from this Agreement, and such court will replace such illegal, void or unenforceable provision of this Agreement with a
valid and enforceable provision that will achieve, to the extent possible, the same economic, business and other purposes of the illegal, void or unenforceable provision. The balance of this Agreement shall be enforceable in accordance with its
terms. 
 7.13 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be enforceable
against the parties actually executing such counterparts, and all of which together shall constitute one instrument. 
 7.14 Telecopy
Execution and Delivery. A facsimile, telecopy or other reproduction of this Agreement may be executed by one or more parties hereto and delivered by such party by facsimile or any similar electronic transmission device pursuant to which the
signature of or on behalf of such party can be seen. Such execution and delivery shall be considered valid, binding and effective for all purposes. At the request of any party hereto, all parties hereto agree to execute and deliver an original of
this Agreement as well as any facsimile, telecopy or other reproduction hereof. 

  
 -16- 

 7.15 Further Assurances. Each party hereto agrees to execute and deliver, by the
proper exercise of its corporate, limited liability company, partnership or other powers, all such other and additional instruments and documents and do all such other acts and things as may be necessary to more fully effectuate this Agreement. 

7.16 Exculpation Among Investors. Each Investor acknowledges that it is not relying upon any other Investor, or any officer,
director, stockholder, employee, agent, partner or affiliate of any such other Investor, in making its investment or decision to invest in the Company or in monitoring such investment. Each Investor agrees that no other Investor nor any officer,
director, stockholder, employee, agent, partner or affiliate of any other Investor shall be liable for any action heretofore or hereafter taken or omitted to be taken by any of them relating to or in connection with the Company or the Series C
Preferred, or both. Without limiting the foregoing, no Investor nor any of its officers, directors, stockholders, partners, employees or agents of affiliates, or other holder of any Series C Preferred shall have any obligation, liability or
responsibility whatsoever for the accuracy, completeness or fairness of any or all information about the Company or any subsidiary or their respective properties, business or financial and other affairs, acquired by such Investor or holder from the
Company or any subsidiary or the respective officers, directors, employees, agents, representatives, counsel or auditors of either, and in turn provided to another Investor or holder of Series C Preferred, nor shall any such Investor or other
Person have any obligation or responsibility whatsoever to provide any such information to any other Investor or holder of Series C Preferred or to continue to provide any such information if any information is provided. 

7.17 Rights of Investors. Each Investor, in its sole and absolute discretion, may exercise or refrain from exercising any rights
or privileges that such Investor may have pursuant to the Agreements, the Restated Certificate, the Bylaws or at law or in equity, and such Investor shall not incur or be subject to any liability or obligation to the Company, any other Investor or
holder of Series C Preferred, any other stockholder or securityholder of the Company or any other person, by reason of exercising or refraining from exercising any such rights or privileges. 

7.18 No Commitment for Additional Financing. The Company acknowledges and agrees that no Investor has made any representation,
undertaking, commitment or agreement to provide or assist the Company in obtaining any financing, investment or other assistance, other than the purchase of the Series C Preferred as set forth in Section 1.2 and subject to the conditions
set forth in Section 5. In addition, the Company acknowledges and agrees that (i) no statements, whether written or oral, made by any Investor or its representatives on or after the date hereof shall create an obligation, commitment or
agreement to provide or assist the Company in obtaining any financing or investment, (ii) the Company shall not rely on any such statement by any Investor or its representatives and (iii) an obligation, commitment or agreement to provide
or assist the Company in obtaining any financing or investment may only be created by a written agreement, signed by such Investor and the Company, setting forth the terms and conditions of such financing or investment and stating that the parties
intend for such writing to be a binding obligation or agreement. Each Investor shall have the right, in its sole and absolute discretion, to refuse or decline to participate in any other financing of or investment in the Company, and shall have no
obligation to assist or cooperate with the Company in obtaining any financing, investment or other assistance. 
 7.19 Waiver of
Potential Conflicts of Interest. Each of the Investors and the Company acknowledges that Wilson Sonsini Goodrich & Rosati, Professional Corporation (“WSGR”) may have represented and may currently represent
certain of the Investors. In the course of such representation, WSGR may have come into possession of confidential information relating to such Investors. 

  
 -17- 

 
Each of the Investors and the Company acknowledges that WSGR is representing only the Company in this transaction. Each of the Investors and the Company understands that an affiliate of WSGR may
also be an Investor under this Agreement. By executing this Agreement, each of the Investors and the Company hereby waives any actual or potential conflict of interest which may arise as a result of WSGR’s representation of such persons and
entities, WSGR’s possession of such confidential information and the participation by WSGR’s affiliate in the financing. Each of the Investors and the Company represents that it has had the opportunity to consult with independent counsel
concerning the giving of this waiver. 
 (Signature pages to follow.) 

  
 -18- 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	UPLAND SOFTWARE, INC.
	a Delaware corporation
		
	By:	 	/s/ JOHN T. MCDONALD
		 	John T. McDonald,
		 	Chief Executive Officer

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	MLPF&S AS CUST. FBO JOHN MCDONALD IRRA
		
	By:	 	/s/ JOHN T. MCDONALD
	Name:	 	John T. McDonald
	Title:	 	Authorized Signatory

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	AUSTIN VENTURES IX, L.P.
	
	By: AV Partners IX, L.P., its General Partner
	By: AV Partners IX, LLC, its General Partner
		
	By:	 	/s/ JOHN THORNTON
	Name:	 	John Thornton
	Title:	 	Member

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	AUSTIN VENTURES X, L.P.
	
	By: AV Partners X, L.P., its General Partner
	By: AV Partners X, LLC, its General Partner
		
	By:	 	/s/ JOHN THORNTON
	Name:	 	John Thornton
	Title:	 	Member

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	ACTIVANT INVESTMENT II, LLC
		
	By:	 	/s/ STEVE SARRACINO
	Name:	 	Steve Sarracino
	Title:	 	Manager

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	ACTIVANT HOLDINGS I, LP
	
	By: ACTIVANT CAPITAL GROUP, LLC
	Its: General Partner
		
	By:	 	/s/ STEVE SARRACINO
	Name:	 	Steve Sarracino
	Title:	 	Manager

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	ACTIVANT HOLDINGS II, LP
	
	By: ACTIVANT CAPITAL GROUP, LLC
	Its: General Partner
		
	By:	 	/s/ STEVE SARRACINO
	Name:	 	Steve Sarracino
	Title:	 	Manager

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	ALTITUDE INVESTMENTS FUND I, L.P.
	
	By: Altitude Investments LLC
	Its: General Partner
		
	By:	 	/s/ BRAD SEIDEL
	Name:	 	Brad Seidel
	Title:	 	President

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/S/ CLAYTON CHRISTOPHER
	Clayton Christopher

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	COVENANT PE I, L.P.
	
	By: Atlas Capital Management, L.P.
	Its: General partner
	
	By: RHA, Inc.
	Its: General partner
		
	By:	 	/s/ ROBERT H. ALPERT
	Name:	 	Robert H. Alpert
	Title:	 	President

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	RARA4 INVESTMENTS, LTD.
	
	By: Tame Coyote Management, LLC
	Its: General partner
		
	By:	 	/s/ DONALD C. REYNOLDS
	Name:	 	Donald C. Reynolds
	Title:	 	Manager

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	COZMO INVESTMENTS, LTD.
	
	By: High 4 Family, LLC
	Its: General partner
		
	By:	 	/s/ WALTER C. REYNOLDS
	Name:	 	Walter C. Reynolds
	Title:	 	Manager

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	ESW CAPITAL LLC
		
	By:	 	/s/ ANDREW S. PRICE
	Name:	 	Andrew S. Price
	Title:	 	CFO

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	GLOBAL UNDERVALUED SECURITIES MASTER FUND, L.P.
		
	By:	 	/s/ JAMES K. PHILLIPS
	Name:	 	James K. Phillips
	Title:	 	Chief Financial Officer

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ ROBERT HERSCH
	Robert Hersch

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ JERALD PETERSON
	Jerald Peterson

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ JOSEPH P. PETERSON
	Joseph P. Peterson

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ JOE ROSS
	Joe Ross

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ KEVIN SINGERMAN
	Kevin Singerman

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	MARGUERITE C. KLEINHEINZ TRUST
		
	By:	 	/s/ JOHN B. KLEINHEINZ
		 	John B. Kleinheinz,
		 	Trustee

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	JOHN BURKE KLEINHEINZ JR. TRUST
		
	By:	 	/s/ JOHN B. KLEINHEINZ
		 	John B. Kleinheinz,
		 	Trustee

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	WILLIAM HARRISON KLEINHEINZ TRUST
		
	By:	 	/s/ JOHN B. KLEINHEINZ
		 	John B. Kleinheinz,
		 	Trustee

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ LEO PETERSON
	Leo Peterson

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ MARK SINGERMAN
	Mark Singerman

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ JAMES PALLOTTA
	James Pallotta

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ BYRON DAVID PEARSON
	Byron David Pearson

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	THE MICHAEL M REYNOLDS TESTAMENTARY TRUST
		
	By:	 	/s/ MIKE REYNOLDS
	Name:	 	Mike Reynolds
	Title:	 	Trustee

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

			
	RICHARD H. HEIN TRUST DATED JUNE 12, 1995
		
	By:	 	/s/ RICHARD H. HEIN
	Name:	 	Richard H. Hein
	Title:	 	Trustee

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ TIMOTHY MAY
	Timothy May

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 The parties are signing this Series C Preferred Stock Purchase Agreement as of the date
stated in the introductory clause. 
  

	
	/s/ GEORGE WOODIWISS
	George Woodiwiss

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

 Exhibit A 

SCHEDULE OF INVESTORS 
 INITIAL CLOSING

  

																	
	 Investor Name and Address
	  	Cancellation
of
Indebtedness1	 	  	Cash	 	  	Total
Purchase
Price	 	  	No. of
Series C
Shares	 
	 Activant Investment II, LLC

[***]
	  	$	1,009,998.72	  	  	$	0.00	  	  	$	1,009,998.72	  	  	 	701,388	  
					
	 Activant Holdings I, LP

[***]
	  	$	0.00	  	  	$	3,699,999.00	  	  	$	3,699,999.00	  	  	 	2,055,555	  
					
	 Activant Holdings II, LP

[***]
	  	$	0.00	  	  	$	3,049,999.20	  	  	$	3,049,999.20	  	  	 	1,694,444	  
					
	 Austin Ventures X, L.P.

[***]
	  	$	1,060,499.52	  	  	$	0.00	  	  	$	1,060,499.52	  	  	 	736,458	  
					
	 Austin Ventures IX, L.P.

[***]
	  	$	706,999.68	  	  	$	0.00	  	  	$	706,999.68	  	  	 	490,972	  
					
	 ESW Capital LLC

[***]
	  	$	512,817.12	  	  	$	1,499,999.40	  	  	$	2,012,816.52	  	  	 	1,189,456	  
					
	 MLPF&S as Cust. FBO John

McDonald IRRA

[***]
	  	$	368,648.64	  	  	$	414,999.00	  	  	$	783,647.64	  	  	 	486,561	  
					
	 Covenant PE I, L.P.

[***]
	  	$	151,544.16	  	  	$	505,999.80	  	  	$	657,543.96	  	  	 	386,350	  
					
	 RARA4 Investments, Ltd.

[***]
	  	$	146,446.56	  	  	$	749,998.80	  	  	$	896,445.36	  	  	 	518,365	  
					
	 Cozmo Investments, Ltd.

[***]
	  	$	146,446.56	  	  	$	749,998.80	  	  	$	896,445.36	  	  	 	518,365	  
					
	 James Pallotta
	  	$	97,938.72	  	  	$	249,998.40	  	  	$	347,937.12	  	  	 	206,901	  
	 [***]
	  				  				  				  			

  

	1 	Shares purchased by cancellation of these Notes are sold at 80% of the Purchase Price pursuant to contractual provisions set forth therein. 

																	
	 Investor Name and Address
	  	Cancellation
of
Indebtedness1	 	  	Cash	 	  	Total
Purchase
Price	 	  	No. of
Series C
Shares	 
	 Marguerite C. Kleinheinz Trust

[***]
	  	$	84,165.12	  	  	$	0.00	  	  	$	84,165.12	  	  	 	58,448	  
					
	 John Burke Kleinheinz Jr. Trust

[***]
	  	$	84,165.12	  	  	$	0.00	  	  	$	84,165.12	  	  	 	58,448	  
					
	 William Harrison Kleinheinz Trust

[***]
	  	$	84,165.12	  	  	$	0.00	  	  	$	84,165.12	  	  	 	58,448	  
					
	 Global Undervalued Securities Master Fund, L.P.

[***]
	  	$	0.00	  	  	$	1,499,999.40	  	  	$	1,499,999.40	  	  	 	833,333	  
					
	 Kevin Singerman

[***]
	  	$	75,447.36	  	  	$	0.00	  	  	$	75,447.36	  	  	 	52,394	  
					
	 Mark Singerman

[***]
	  	$	75,447.36	  	  	$	0.00	  	  	$	75,447.36	  	  	 	52,394	  
					
	 Jerald Peterson

[***]
	  	$	65,144.16	  	  	$	49,998.60	  	  	$	115,142.76	  	  	 	73,016	  
					
	 Leo Peterson

[***]
	  	$	65,144.16	  	  	$	94,998.60	  	  	$	160,142.76	  	  	 	98,016	  
					
	 Joseph P. Peterson

[***]
	  	$	0.00	  	  	$	104,999.40	  	  	$	104,999.40	  	  	 	58,333	  
					
	 Clayton Christopher

[***]
	  	$	50,499.36	  	  	$	124,999.20	  	  	$	175,498.56	  	  	 	104,513	  
					
	 Richard H. Hein Trust dated June 12, 1995

[***]
	  	$	33,675.84	  	  	$	112,602.60	  	  	$	146,278.44	  	  	 	85,943	  
					
	 Joe Ross

[***]
	  	$	25,256.16	  	  	$	29,998.80	  	  	$	55,254.96	  	  	 	34,205	  
					
	 George Woodiwiss

[***]
	  	$	90,174.24	  	  	$	0.00	  	  	$	90,174.24	  	  	 	62,621	  
					
	 Altitude Investments Fund I, L.P.

[***]
	  	$	0.00	  	  	$	1,399,998.60	  	  	$	1,399,998.60	  	  	 	777,777	  

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement) 

																	
	 Investor Name and Address
	  	Cancellation
of
Indebtedness1	 	  	Cash	 	  	Total
Purchase
Price	 	  	No. of
Series C
Shares	 
	 The Michael M Reynolds

Testamentary Trust

[***]
	  	$	0.00	  	  	$	249,998.40	  	  	$	249,998.40	  	  	 	138,888	  
					
	 Byron David Pearson

[***]
	  	$	0.00	  	  	$	99,999.00	  	  	$	99,999.00	  	  	 	55,555	  
					
	 Timothy May

[***]
	  	$	0.00	  	  	$	149,999.40	  	  	$	149,999.40	  	  	 	83,333	  
					
	 Robert Hersch

[***]
	  	$	0.00	  	  	$	49,998.60	  	  	$	49,998.60	  	  	 	27,777	  
					
	 TOTAL
	  	$	4,934,623.68	  	  	$	14,888,583.00	  	  	$	19,823,206.68	  	  	 	11,698,257	  

  
 (Signature page
to the Series C Preferred Stock Purchase Agreement)EX-10.37

 Exhibit 10.37 

 
 AMENDED AND RESTATED TECHNOLOGY SERVICES AGREEMENT 

Effective Date: 
 January 1, 2014 

 

 This Amended and Restated Technology Services Agreement (“Agreement”) is entered into by and between
DevFactory FZ-LLC, 705-706 Al Thuraya Tower No. 01, Seventh Floor, Dubai Media City, P.O. Box 502092, Dubai, 43659 UNITED ARAB EMIRATES (“DevFactory”) and Upland Software, Inc. (f.k.a. Silverback Enterprise Group, Inc.,
“Client”), with offices at 401 Congress Avenue, Austin, Texas 78701, and sets forth the terms and conditions under which DevFactory will provide certain technology services to Client as may from time to time be mutually agreed upon by the
parties. 
 1 Scope of Services 
 1.1 Deliverables
Based Work. Unless otherwise provided on a Statement of Work, all Work to be performed hereunder shall be performed on a scoped deliverable basis and not on a time and material basis. The parties shall work in good faith to specify the
applicable deliverables in the applicable SOW. 
 1.2 Statements of Work. DevFactory agrees to provide the technology services (“Services”)
described on separate, mutually executed statements of work (the “Statement(s) of Work” or SOW(s)”) as may from time to time be issued hereunder. Each Statement of Work shall define the Services to be provided to Client, the
applicable pricing, Deliverables to be created thereunder, Client deliverables and obligations, and all other appropriate terms and conditions. DevFactory will not begin any work unless a Statement of Work governing has been executed by both
parties. DevFactory may immediately cease performing Services, without liability, if a Statement of Work expires and is not immediately extended or replaced with a valid Statement of Work. 

1.3 Change Control Process. Change control for additional Services or scope to be delivered under a Statement of Work will be completed according to
the following procedure prior to DevFactory starting any work. 
  

	 	(a)	Specific changes may be proposed by Client’s business team members. 

  

	 	(b)	Proposed changes will be reviewed by DevFactory and a report of the scope, schedule, resource and budget impact (“Impact Report”) will be prepared and delivered to Client management. 

 

	 	(c)	Client management reviews the Impact Report and approves by signature or denies changes in scope, schedule, resources and/or budget. 

 

	 	(d)	DevFactory receives the signed, approved Impact Report and creates. for Client’s approval, an additional Statement of Work with a copy of the Impact Report attached. 

 

	 	(e)	Client approves by signature such Statement of Work and delivers such Statement of Work to DevFactory for DevFactory’s signature.

	 	(f)	DevFactory begins work on specific changes defined in the signed, approved Impact Report only upon the mutual execution of the new Statement of Work referenced above. 

1.4 Testing and Acceptance. Following completion of any Deliverable (as defined below) to be provided to Client hereunder, Client may test the
Deliverable to determine whether the Deliverable conforms to the specifications established for such Deliverable in the applicable SOW for a period not to exceed thirty (30) days after delivery to Client of the Deliverable (the “Acceptance
Period”). Upon the expiration of the Acceptance Period, Client will either (i) certify to DevFactory that the Deliverable is accepted (“Acceptance”); or (ii) deliver to DevFactory a written description of any specific
failure of the Deliverable to conform to the applicable specifications. In no such written response is provided, the Deliverable shall be deemed to be Accepted and complete. Further, if the Deliverable substantially conforms to the specifications
but Client identifies certain minor non-conformities, Client shall Accept the Deliverable and the parties shall work in good faith to either correct such non-conformities or agree on appropriate Work Credits (as defined below) to compensate Client
for such non-conformities. Upon proper notice of a failure of Acceptance, DevFactory will promptly undertake such corrections as are necessary for the Deliverable to conform to the specifications and DevFactory will notify Client when such
corrections and modifications have been made. If DevFactory has performed corrections to the Deliverable, Client will have thirty (30) days after delivery of such corrections to perform acceptance testing to determine whether the Deliverable
conforms to the applicable specifications. If after a second attempt the Deliverable still does not conform to the applicable specifications, Client shall have the right to (1) allow continued attempts to correct the Deliverable, subject to
this Section 1.4, or (2) terminate the applicable service obligation for the failed deliverable and receive a Work Credit (as defined below) as to just that failed Deliverable. If DevFactory notifies Client that Client has failed to
properly provide notice that a Deliverable has failed, if Client otherwise improperly fails to Accept a Deliverable, or if the parties disagree as to whether a Deliverable substantially conforms to the specifications, such dispute shall be resolved
in accordance with Section 12.16. For clarity, any concerns by Client that a Deliverable does not meet Client’s expectations, but otherwise complies with all applicable specifications, shall not be actionable under this provision, but,
rather, shall constitute an additional service request. 
 1.5 Order of Precedence. Each Statement of Work shall be governed by the terms and
conditions of this Agreement (including its schedules and attachments); however, in the event of any conflict between this Agreement and a Statement of Work the provisions of the Statement of Work shall prevail. 

2 Subcontractors 
 2.1 Client acknowledges that
DevFactory shall subcontract Services to a third party (“Subcontractor”), subject to provisions contained under Section 5.4. DevFactory shall be responsible for the

 

 
Subcontractor’s compliance with this Agreement. Client understands that the Subcontractors shall be foreign nationals and may be located in a country other than the United States (but will
not be located in Iran, Sudan, Syria, Iraq, Cuba or North Korea or any other country subject to embargo or other restrictions by the United States government). Either party warrants that any export of its Confidential Information, data or software,
and its performance hereunder, will comply with all foreign and domestic federal, state and local laws and ordinances, including any and all import and export restrictions and all customs requirements. 

3 Term 
 3.1 Agreement Term. This Agreement shall
commence on the Effective Date and shall remain in force for an initial period of forty-eight (48) months and shall automatically renew for up to five successive one year periods thereafter at the election of either party as provided herein. If
both parties have failed to indicate a desire to renew a term prior to the date that is thirty (30) days prior to the then current expiration date, each party shall provide written notice to the other seeking to confirm such other party’s
desire not to renew. Each party shall have thirty days to confirm its position on renewal or non renewal. The Agreement shall continue in effect through the confirmation process. 

3.2 Statement of Work Term. Each Statement of Work shall remain in effect until it has expired on its own terms or the Services and Deliverables
authorized thereunder are complete. The parties agree that they are contractually obligated to enter into Statements of Work pursuant to the structure set forth in Schedule A which is attached hereto and made a part hereof. As such, Schedule A sets
forth the percentage of revenue of any and all entities and business lines acquired by Client that is payable to DevFactory throughout the term of the Agreement and likewise, DevFactory hereby agrees to provide the Deliverables as to all entities
acquired by Client as per Schedule A. 
 4 Price and Payment 

4.1 Service Fees. In consideration of the Services provided by DevFactory, Client shall pay the Services Fees set forth in the applicable Statement of
Work or as otherwise provided on Schedule A, subject to the payment provisions set forth in Schedule A. In the event a Statement of Work does not reference any specific pricing, such Services shall be provided at rates and charges in accordance with
Section 4 of Schedule A. 
 4.2 Expenses. Client shall reimburse DevFactory for all reasonable travel, food, lodging and other out-of-pocket
expenses incurred in performance of a given Statement of Work. DevFactory shall obtain Client’s prior written expense prior to incurring any single expense in excess of $500. 

4.3 Payment Due Date. DevFactory will submit invoices for charges and expenses hereunder monthly. Client shall make payment of each invoice in US
dollars within thirty (30) days from the invoice date. Notwithstanding any provision to the contrary, any and all payments required to be made hereunder shall be timely made, and no payments to DevFactory shall be withheld, delayed, reduced or
refunded if DevFactory has fully performed its material obligations and its inability to meet any schedule or delivery requirements is caused by Client’s failure to provide certain of its facilities, computer resources, software programs,
project management activities, personnel, and business information as are required to perform any work. 
 4.4 Purchase Orders. Client agrees to
provide DevFactory with a valid purchase order, if applicable, promptly upon execution of a Statement of Work. Notwithstanding

 
anything to the contrary herein, purchase orders are to be used solely for Client’s accounting purposes and any terms and conditions contained therein shall be deemed null and void with
respect to the parties’ relationship and this Agreement. Client’s failure to issue a purchase order or provide such purchase order to DevFactory, however, shall in no way relieve Client of any obligation entered into pursuant to this
Agreement or any Statement of Work entered into hereunder, including, but not limited to, its obligation to pay DevFactory in a timely fashion. 
 4.5
Late Payment. Any late payment shall be subject to any costs of collection (including reasonable legal fees) and shall bear interest at the rate of one and one-half percent (1.5%) per month (prorated for partial periods) or at the
maximum rate permitted by law, whichever is less. In addition to other rights and remedies available to DevFactory hereunder and under the law, DevFactory shall have the right to withdraw all consulting staff as well as all unfinished Services or
Deliverables performed under a Statement of Work in the event of Client’s failure to pay any undisputed (a dispute as to invoice may only be commenced on the basis of proper form or amount for such invoice) open invoice within thirty
(30) days following the due date. The Services will not be restaffed until: (i) all amounts due to DevFactory have been paid in full; (ii) any and all contractual terms and/or deadlines that have been affected by the delay have been
revised and agreed upon by the parties; and (iii) DevFactory resources have become available for redeployment on Client’s project. 
 4.6
Taxes. The charges required to be paid hereunder do not include any amount for taxes or levy (including interest and penalties). Client shall reimburse DevFactory and hold DevFactory harmless for all sales, use, VAT, excise, property, or
other taxes or levies which DevFactory is required to collect or remit to applicable tax authorities. This provision does not apply to DevFactory’s income or franchise taxes, or any taxes for which Client is exempt, provided Client has
furnished DevFactory with a valid tax exemption certificate. 
 4.7 Invoice Dispute Resolution. Without limiting any rights or obligations under the
Agreement, including Section 4.5 above, the following steps will be taken if an invoice becomes past due. DevFactory’s accounts receivable and Client’s accounts payable representatives shall use all reasonable efforts to facilitate
immediate payment of the invoice. In the event DevFactory does not receive a commitment for prompt payment, each party shall escalate the matter to DevFactory’s Primary Contact for the Services in question, as designated in the Statement of
Work, or DevFactory’s designated financial officer and Client’s Chief Executive Officer (the “Final Escalation”) for investigation and resolution. Notwithstanding anything to the contrary, the initial contact with Client’s
vice president pursuant to such Final Escalation shall constitute “notice of default” pursuant to Section 9.1.1. 
 5
Confidential/Proprietary Information 
 5.1 Definition. All information which is defined as Confidential Information hereunder in tangible form
shall be marked as “Confidential” or the like or, if intangible (e.g. visually or orally disclosed), shall be designated as being confidential at the time of disclosure and shall be confirmed as such in writing within thirty (30) days
of the initial disclosure. “Confidential Information” may include all technical, product, business, financial, and other information regarding the business and software programs of either party, its customers, employees, investors,
contractors, vendors and suppliers, including but not limited to programming techniques and methods, research and development, computer programs, documentation, marketing plans, customer identity, and business methods. Without limiting the
generality of the foregoing and notwithstanding any marking requirement, Confidential Information shall include all

 

  

			
	Technology Services Agreement	  	Page 2

 
information and materials disclosed orally or in any other form, regarding DevFactory’s software products or software product development and other information of or relating to
DevFactory’s software products or derived from testing or other use thereof. All such Confidential Information may be disclosed by either party, before or after the Effective Date. Confidential Information includes information generally not
publicly known, whether tangible or intangible and in whatever form or medium provided, as well as any information generated by a party that contains, reflects, or is derived from such information. For the purpose of this entire Section 5,
‘DevFactory’ shall include all its Affiliates. 
 5.2 Exceptions. Without granting any right or license, the obligations of the parties
hereunder shall not apply to any material or information that: (i) is or becomes a part of the public domain through no act or omission by the receiving party; (ii) is independently developed by the receiving party without use of the
disclosing party’s Confidential Information; (iii) is rightfully obtained from a third party without any obligation of confidentiality to the receiving party; or (iv) is already known by the receiving party without any obligation of
confidentiality prior to obtaining the Confidential Information from the disclosing party. In addition, neither party shall be liable for disclosure of Confidential Information if made in response to a valid order of a court or authorized agency of
government, provided that notice is promptly given to the party whose Confidential Information is to be disclosed so that such party may seek a protective order and engage in other efforts to minimize the required disclosure. The parties shall
cooperate fully in seeking such protective order and in engaging in such other efforts. Notwithstanding the foregoing, except for intellectual property owned by DevFactory prior to execution of the applicable SOW or developed separately by
DevFactory for which fees were not paid to DevFactory hereunder (“DevFactory Pre-existing Technology”), Deliverables provided to Client hereunder are the Confidential Information of Client and shall not be subject to the exceptions set
forth in this Section 5.2. 
 5.3 Ownership of Confidential Information. Nothing in this Agreement shall be construed to convey any title or
ownership rights to the DevFactory Confidential Information or to any patent, copyright, trademark, or trade secret embodied therein, or to grant any other right title, or ownership interest in the DevFactory Confidential Information to Client.
Nothing in this Agreement shall be construed to convey any title or ownership rights to Client’s Confidential Information or to any patent, copyright, trademark, or trade secret embodied therein, or to grant any other right, title, or ownership
interest in the Client’s Confidential Information to DevFactory. Neither party shall disassemble, decompile, or reverse engineer the other party’s Confidential Information or permit others to do so. Neither party shall, in whole or in
part, sell, lease, license, assign, transfer, or disclose the Confidential Information to any third party and shall not copy, reproduce or distribute the Confidential Information except as expressly permitted in this Agreement. Each party shall take
every reasonable precaution, but no less than those precautions used to protect its own Confidential Information, to prevent the theft, disclosure, and the unauthorized copying, reproduction or distribution of the Confidential Information. 

5.4 Non-Disclosure. Each party agrees at all times to use all reasonable efforts, but in any case no less than the efforts that each party uses in the
protection of its own Confidential Information (as hereinafter defined) of like value to protect Confidential Information belonging to the other party. Each party agrees to restrict access to the other party’s Confidential Information only to
those employees (or in DevFactory’s case, its Subcontractors) who (i) require access in the course of their assigned duties and responsibilities, and (ii) have

 
agreed in writing to be bound by provisions no less restrictive than those set forth in this Section 5. 

5.5 Injunctive Relief. Each party acknowledges that any unauthorized disclosure or use of the Confidential Information would cause the other party
imminent irreparable injury and that such party shall be entitled to, in addition to any other remedies available at law or in equity, temporary, preliminary, and permanent injunctive relief in the event the other party does not fulfill its
obligations under this Section 5. 
 5.6 Prohibition Against Individual Agreements. Client agrees that no employees or Subcontractors of
DevFactory shall be required to individually sign any agreement in order to perform Services hereunder, including but not limited to access agreements, security agreements, facilities agreements or individual confidentiality agreement. 

5.7 Affiliates. For the purpose of this entire Section 5 ‘DevFactory’ shall include all its Affiliates. 

5.8 Return of Confidential Information. Upon the written request of disclosing party or termination of this Agreement, receiving party shall return or
destroy (and certify such destruction in a signed writing) all Confidential Information of disclosing party, including all copies thereof and materials incorporating such Confidential Information, whether in physical or electronic form. Each party
may retain a copy of the other party’s Confidential Information solely for archival purposes. To the extent that it is impracticable to return or destroy any Confidential Information, and with respect to any copies retained for archival
purposes, receiving party shall continue to maintain the Confidential Information in accordance with this Agreement. The confidentiality obligations set forth in this Agreement shall survive the termination of this Agreement and remain in full force
and effect until such Confidential Information, through no act or omission of receiving party, ceases to be Confidential Information as defined hereunder. 

6 Client’s Support 
 6.1 To the extent reasonably
required by DevFactory, Client will make available to DevFactory certain of its programs, networks, personnel, and business information as are required to perform any Statement of Work hereunder. DevFactory agrees to comply with Client’s
network access rules and regulations regarding safety, security, and conduct provided DevFactory has been made aware of such rules and regulations. 
 7
Warranties 
 7.1 DevFactory warrants that it has the right to enter into this Agreement and grant the rights and licenses set forth herein, and that
all Services performed under this Agreement shall be performed in a workmanlike and professional manner. 
 7.2 EXCEPT AS OTHERWISE STATED IN THIS
AGREEMENT, ANY AND ALL SERVICES, DELIVERABLES, CUSTOMIZATIONS, DOCUMENTATION, CONFIDENTIAL INFORMATION AND ANY OTHER TECHNOLOGY OR MATERIALS PROVIDED BY DEVFACTORY TO THE CLIENT ARE PROVIDED “AS IS” AND WITHOUT WARRANTY OF ANY KIND,
WHETHER EXPRESS OR IMPLIED INCLUDING EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT. 
 7.3
CLIENT’S SOLE REMEDY FOR ANY FAILURE OF THE FOREGOING WARRANTY AND EXCLUSIVE REMEDY FOR ANY FAILURE OF ANY KIND OF SERVICES OR

 

  

			
	Technology Services Agreement	  	Page 3

 
DELIVERABLES SUBMITTED BY DEVFACTORY SHALL BE (I) TO OBTAIN THE REPAIR, REPLACEMENT, AND CORRECTION OF THE DEFECTIVE SERVICES OR DELIVERABLES BY DEVFACTORY IN ACCORDANCE WITH SECTION 1.4, OR
(II) TO OBTAIN A CREDIT EQUAL TO THE AMOUNTS ATTRIBUTABLE TO THE DEFECTIVE SERVICES OR DELIVERABLES WITH SUCH CREDIT TO BE UTILIZED FOR A FUTURE DELIVERABLE (THE “WORK CREDIT”). SHOULD A WORK CREDIT BE ISSUED, IT SHALL BE APPLIED TO THE
PURCHASE OF ADDITIONAL WORK ABOVE AND BEYOND WORK PERFORMED FOR THE MINIMUM FEE (AS DEFINED IN SCHEDULE A) AND SHALL NOT, EXCEPT AS PROVIDED BELOW, REDUCE PAYMENTS DUE OR PAYABLE TO DEVFACTORY UNDER THE AGREEMENT. THE MINIMUM FEE SHALL BE APPLIED TO
ALL WORK PERFORMED BEFORE ANY WORK CREDITS ARE APPLIED, AND UNUSED WORK CREDITS SHALL CARRY OVER TO FUTURE YEARS (“WORK CREDIT BALANCE”). IF CERTAIN TYPES OF SERVICES ARE CONSISTENTLY LEADING TO THE ACCUMULATION OF WORK CREDITS, CLIENT AND
DEVFACTORY SHALL WORK TOGETHER IN GOOD FAITH TO ALLOCATE WORK CREDITS TO THE TYPES OF SERVICES THAT CAN BE SUCCESSFULLY DELIVERED BY DEVFACTORY, PROVIDED THAT CLIENT HAS A NEED FOR SUCH SERVICE (EVEN IF THAT NEED HAD BEEN FULFILLED BY EMPLOYEES OR
OTHER PROVIDERS). IF (A) CLIENT HAS APPLIED ITS WORK CREDITS AND SERVICE REQUESTS TO THE RECOMMENDED SERVICES AS DESCRIBED ABOVE AND (B) THE WORK CREDIT BALANCE EXCEEDS 10% OF THE PREVIOUS YEAR’S MINIMUM FEE, AND (C) DEVFACTORY
HAS NOT WORKED IN GOOD FAITH UNDER THIS AGREEMENT, THEN THE CURRENT YEAR’S MINIMUM FEE SHALL BE REDUCED BY THE DIFFERENCE BETWEEN THE WORK CREDIT BALANCE AND 10% OF THE PREVIOUS YEAR’S MINIMUM FEE. THE WORK CREDIT BALANCE SHALL BE REDUCED
BY THE SAME AMOUNT. 
 8 Limitation of Liability 
 8.1
IN NO EVENT SHALL EITHER PARTY, OR ITS SUBCONTRACTORS OR THIRD PARTY LICENSORS BE LIABLE ON ANY THEORY OF LIABILITY, WHETHER IN AN EQUITBALE, LEGAL, OR COMMON LAW ACTION ARISING HEREUNDER FOR CONTRACT, STRICT LIABILITY, INDEMNITY, TORT (INCLUDING
NEGLIGENCE), OR OTHERWISE, FOR DAMAGES WHICH, IN THE AGGREGATE, EXCEED THE AMOUNT OF CHARGES PAID OR PAYABLE BY CLIENT HEREUNDER FOR THE SERVICES AND/OR DELIVERABLES WHICH GAVE RISE TO SUCH DAMAGES (PROVIDED IN THE RESPECTIVE STATEMENT OF WORK) AND
NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY REMEDY. IN ALL INSTANCES, CLIENT’S SOLE REMEDY AS TO QUALITY OF SERVICES SHALL BE TO SEEK RE-PERFORMANCE OF THE WORK OR A FUTURE WORK CREDIT AS SET FORTH IN SECTION 7.3. 

8.2 IN NO EVENT SHALL EITHER PARTY OR ITS SUBCONTRACTORS OR THIRD PARTY LICENSORS BE LIABLE FOR ANY SPECIAL, INCIDENTAL, INDIRECT, EXEMPLARY, PUNITIVE, OR
CONSEQUENTIAL DAMAGES OF ANY KIND AND HOWEVER CAUSED, INCLUDING BUT NOT LIMITED TO BUSINESS INTERRUPTION OR LOSS OF PROFITS, BUSINESS OPPORTUNITIES. OR GOOD WILL EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGE, AND

 
NOTWITHSTANDING THE FAILURE OF ESSENTIAL PURPOSE OF ANY REMEDY. 
 8.3 The limitations of liability
and exclusion of damages set forth in Sections 8.1 shall not apply to breach of Section 5 or to a party’s indemnification obligations herein. 

9 Termination 
 9.1 This Agreement, any license granted
herein, and/or any Statement of Work may be terminated prior to expiration or completion in accordance with the following: 
  

	 	9.1.1	By DevFactory by giving prior written notice to Client if Client fails to perform any material obligation required of it hereunder, and such failure is not cured within thirty (30) days of Client’s
receipt of DevFactory’s notice to cure such non-performance of material obligation. 

  

	 	9.1.2	By Client by giving prior written notice to DevFactory if DevFactory fails to perform any material obligation required of it hereunder, and such failure is not cured within thirty (30) days from
DevFactory’s receipt of Client’s notice to cure such non-performance of material obligation. 

 9.2 Effect of Termination.
Upon termination of this Agreement, Client’s rights to any Deliverables not paid for, DevFactory Confidential Information, and other DevFactory materials (except for those DevFactory materials included in Deliverables owned by Client) (all
collectively “Materials”) shall cease. Client shall immediately stop using such Materials and shall return such Materials to DevFactory or destroy all copies thereof. In addition, Client shall provide DevFactory with written certification
signed by an officer of Client that all copies of the Materials have been returned or destroyed and that no copies have been retained by Client for any purpose whatsoever. Following termination, any use of the Materials by Client shall be an
infringement and/or misappropriation of DevFactory’s proprietary rights in the Materials. Upon termination of this Agreement by Client, DevFactory shall have no further obligation or liability hereunder and all fees due under the Agreement
shall become due and payable to DevFactory immediately upon such termination. Termination of this Agreement or any license created hereunder shall not limit either party from pursuing other remedies available to it, nor shall such termination
relieve Client’s obligation to pay all fees that have accrued or are otherwise owed by Client under this Agreement including, but not limited to, any License schedule, Statement of Work, or exhibit. 

10 Ownership 
 10.1 Ownership in Deliverables. By
signing this Agreement and subject to Client’s full payment for Services provided and Deliverables created under an applicable Statement of Work, DevFactory acknowledges that, subject to the licenses granted herein, DevFactory has no ownership
interest in the Deliverables, or Materials provided to Client. Client shall own all right, title, and interest in such Deliverables, or Materials, subject to any limitations associated with intellectual property rights of third parties, and
DevFactory hereby assigns all right, title and interest in and to such Deliverables and Materials, including without limitation all accompanying worldwide intellectual property rights. 

10.2 Rights to Deliverables. Client hereby grants to DevFactory, a perpetual, royalty free, internal, worldwide, nonexclusive, nontransferable license
to the object code and source code versions of the Deliverables to use the code, techniques,

 

  

			
	Technology Services Agreement	  	Page 4

 
strategies and know-how contained in the Deliverables for other projects and development, if and for so long as any Confidential Information of Client incorporated into such Deliverables, are not
provided to, or included in any deliverable provided to, any third party. For clarity, provided that the Deliverables have been made generic. as described in the preceding provision, DevFactory shall have the perpetual, royalty free, worldwide,
nonexclusive, nontransferable and irrevocable right and license to (i) modify and otherwise create derivative works based on the generic Deliverables, and (ii) reproduce, distribute, perform, display (publicly or otherwise), and otherwise
use and exploit the generic Deliverables and derivative works thereof; but DevFactory may not use, license or distribute software programs as a whole, but may use, license and distribute, generic routines, algorithms, and other portions of the
software programs. 
 10.3 Ownership in the event of material breach. Notwithstanding anything provision to the contrary herein (including sections
10.1 and 10.2 above), in the event that there is a termination of this Agreement, or any SOW, as a result of a material breach by Client of this Agreement and/or any such SOW, any and all rights, title and interest in any applicable Deliverables or
Materials for which Client has not made full payment shall automatically revert to DevFactory and the Client shall have no ownership rights whatsoever therein. Promptly after notification from DevFactory, the Client shall undertake any and all
reasonable actions to assert DevFactory’s right, title and interest in such Deliverables and Materials. In the event of Deliverables or Materials for which partial payment has been made, the parties shall discuss in good faith whether a partial
Deliverable or a refund shall be provided to Client. 
 10.4 No Support of Deliverables. DevFactory shall have no support and enhancement obligations
related to any Deliverable except as otherwise mutually specified in a Statement of Work. 
 10.5 Third Party Rights. Client acknowledges that in the
event DevFactory provides Services pertaining to any third party products required by Client (including software, hardware, equipment or any other material), all rights in such third party products (“Third Party Rights”) are retained by
the respective third party. Client shall be required to obtain any Third Party Rights from the respective third party directly and any rights in the DevFactory Services related to such Third Party Rights shall be subject to Client’s agreement
with the respective third party. If any such Third Party Rights are included in the Deliverables by DevFactory, or if DevFactory includes any DevFactory Pre-existing Technology, then DevFactory hereby grants to Client a worldwide, perpetual,
irrevocable right and license to use, copy, market, promote and make derivative works of the foregoing, and to make, have made, sell, have sold, import and export products incorporating any of the foregoing. DevFactory shall consult with Client, and
obtain Client’s prior written consent, prior to including any Third Party Rights or DevFactory Pre-existing Technology in any Deliverables. 
 10.6
Further Rights. Nothing in this Agreement shall preclude DevFactory from using in any manner or for any purpose it deems necessary, the know-how, techniques, or procedures acquired or used by DevFactory in the performance of Services
hereunder. 
 11 INDEMNIFICATION. 
 11.1
Infringement Indemnity. DevFactory will defend any action brought against Client to the extent that it is based upon a claim that the Deliverables, as provided by DevFactory to Client under this Agreement and used within the scope of this
Agreement, infringe any patent, trademark, trade secret, copyright or other intellectual property right of a third party, and will pay any costs, damages and reasonable

 
attorneys’ fees attributable to such claim incurred by Client, provided that Client: (a) promptly notifies DevFactory in writing of the claim; (b) grants DevFactory sole control of
the defense and settlement of the claim; and (c) provides DevFactory with all reasonable assistance, information and authority required for the defense and settlement of the claim. 

11.2 Injunctions. If Client’s use of any of the Deliverables hereunder is, or in DevFactory’s opinion is likely to be, enjoined due to the
type of infringement specified in Section 11.1 above, DevFactory may, at its sole option and expense: (a) procure for Client the right to continue using such Deliverables under the terms of this Agreement; (b) replace or modify such
Deliverables so that they are non-infringing and substantially equivalent in function to the enjoined Deliverables; or (c) if options (a) and (b) above cannot be accomplished despite DevFactory’s reasonable efforts, then
DevFactory may terminate Client’s rights and DevFactory’s obligations hereunder with respect to such Deliverables and refund to Client the fees paid hereunder for such Deliverables. 

11.3 Exclusions. Notwithstanding the terms of Section 11.1, DevFactory will have no liability for any infringement claim of any kind to the extent
it results from: (a) modification of the Deliverables made other than by DevFactory or DevFactory’s contractors or agents; or (b) compliance by DevFactory with designs, plans or specifications furnished by or on behalf of Client. 

12 General Terms and Conditions 
 12.1
Import/Export. Each party shall comply with all then-current export and import laws and regulations of the United States and such other governments as are applicable. 

12.2 Compliance with Laws. Both parties agree to comply with all applicable laws, regulations, and ordinances relating to such party’s performance
under this Agreement. 
 12.3 Assignment. Neither party may assign this Agreement or transfer any license created hereunder, by operation of law,
change of control or otherwise (“Assign”) without the prior written consent of the other party, and such consent shall not be unreasonably withheld. Notwithstanding the language of this Section 12.3, however, a party (the
“Assigning Party”) may Assign this Agreement to any person, firm or corporation which, through merger, acquisition by or of the Assigning Party or otherwise, succeeds to all or substantially all of the Assigning Party’s business,
provided (i) the Assigning Party provides the other party with thirty (30) days prior written notice; (ii) the assignee does not compete directly or indirectly with the other party; (iii) the Assigning Party and any assignee are
current in all fees or other obligations due hereunder to the other party; (iv) any such assignee agrees in writing to be bound by the terms and conditions of this Agreement; and (v) if Client is the Assigning Party, the licenses and
rights of Client under this Agreement shall apply to, and may be exercised only in connection with, the operations of Client as they exist on the date of the acquisition, and the Deliverables, Materials, and Confidential Information of DevFactory
may be made available only to Client personnel working in such operations. In the event that Client is subject to a change in control, at DevFactory’s option and election, the Minimum Fee (as set forth in Schedule A) following such change in
control shall become set (without being subject to change thereafter) to the then current Minimum Fee amount in effect at the time of the acquisition. 

12.4 Survival. The provisions set forth in sections 4, 5, 7, 8, 9.2, 10, 11 and 12 of this Agreement shall survive termination or expiration of this
Agreement and any applicable license hereunder. 

 

  

			
	Technology Services Agreement	  	Page 5

 12.5 Notices. Any notice required under this Agreement shall be given in writing and shall be deemed
effective upon delivery to the party addressed. All notices shall be sent to the applicable address specified on the face page hereof or to such other address as the parties may designate in writing. Unless otherwise specified, all notices to
DevFactory shall be sent to the attention of the Contracts Manager. Any notice of material breach pursuant to Section 9 shall clearly define the breach including the specific contractual obligation that has been breached. 

12.6 Force Majeure. DevFactory shall not be liable to Client for any delay or failure of DevFactory to perform, its obligations hereunder if such delay
or failure arises from any cause or causes beyond the reasonable control of DevFactory. Such causes shall include, but are not limited to, acts of God, floods, fires, loss of electricity or other utilities (unless due to DevFactory’s acts or
omissions), or delays by Client in providing required resources or support or performing any other requirements hereunder, 
 12.7 Conflict. In the
event of a conflict between the terms and conditions of this Agreement, a License Schedule, an exhibit, or a Statement of Work, the terms and conditions of the SOW, license schedule or exhibit shall prevail, in that order. 

12.8 Restricted Rights. Use of the Deliverables and/or Materials by or for the United States Government is conditioned upon the Government agreeing
that the Deliverables and/or Materials are subject to Restricted Rights as provided under the provisions set forth in FAR 52.227-19. Client shall be responsible for ensuring that this provision is included in all agreements with the United States
Government and that the Deliverables and Materials, when delivered to the Government, is correctly marked as required by applicable Government regulations governing such Restricted Rights as of such delivery, 

12.9 Entire Agreement. This Agreement (including any schedules or attachments hereto), and including any separately executed Statements of Work and any
exhibits, shall constitute the entire agreement between the parties regarding the subject matter hereof and supersede all proposals and prior discussions and writings between the parties with respect thereto, including without limitation the
Technology Services Agreement entered into between DevFactory LLC-FZ and Silverback Enterprise Group, Inc. on January 18, 2012 and the Amendment #1 thereto entered into on January 26, 2012, which agreements shall be of no further force and
effect as of the date hereof, which agreements shall be deemed fully performed with no further obligations by one party to the other owed thereunder and of no further force and effect as of the date hereof. 

12.10 Modifications. The parties agree that this Agreement, and any SOW executed hereunder, cannot be altered, amended or modified, except by a writing
signed by an authorized representative of each party. 
 12.11 Nonsolicitation. During the term of this Agreement and for a period of one
(1) year thereafter, each party agrees not to solicit, nor attempt to solicit, the services of any employee or Subcontractor of the other party without the prior written consent of such other party. Each party further agrees not to solicit nor
attempt to solicit, the services of any former employee or Subcontractor of the other party for a period of six (6) months from such former employee’s or Subcontractor’s last date of service with the other party. Violation of this
provision shall entitle the aggrieved party to liquidated damages against the violating party equal to two hundred percent (200%) of the solicited person’s gross annual compensation. Generalized employment searches, such as Internet
postings, classified advertising, job fairs or the like, shall not violate this Section 12.11.

 12.12 Headings. Headings are for reference purposes only, have no substantive effect, and shall not enter
into the interpretation hereof. 
 12.13 No Waiver. No failure or delay in enforcing any right or exercising any remedy will be deemed a waiver of
any right or remedy. 
 12.14 Severability and Reformation. Each provision of this Agreement is a separately enforceable provision. If any provision
of this Agreement is determined to be or becomes unenforceable or illegal, such provision shall be reformed to the minimum extent necessary in order for this Agreement to remain in effect in accordance with its terms as modified by such reformation.

 12.15 Independent Contractor. DevFactory is an independent contractor and nothing in this Agreement shall be deemed to make DevFactory an agent,
employee, partner or joint venturer of Client. Neither party shall have authority to bind, commit, or otherwise obligate the other party in any manner whatsoever. 

12.16 Dispute Resolution. Any dispute, controversy or claim arising under, out of or relating to this contract and any subsequent amendments of this
contract, including, without limitation, its formation, validity, binding effect, interpretation, performance, breach or termination, as well as non-contractual claims, shall be submitted to mediation in accordance with the WIPO Mediation Rules. The
place of mediation shall be Austin, Texas, USA. The language to be used in the mediation shall be English. 
 If, and to the extent that,
any such dispute. controversy or claim has not been settled pursuant to the mediation within sixty (60) days of the commencement of the mediation, it shall, upon the filing of a Request for Arbitration by either party, be referred to and
finally determined by arbitration in accordance with the WIPO Expedited Arbitration Rules. Alternatively, if, before the expiration of the said period of sixty (60) days, either party fails to participate or to continue to participate in the
mediation, the dispute, controversy or claim shall, upon the filing of a Request for Arbitration by the other party, be referred to and finally determined by arbitration in accordance with the WIPO Expedited Arbitration Rules. The place of
arbitration shall be Austin, Texas, USA. The language to be used in the arbitral proceedings shall be English. The parties acknowledge and agree that mediation and arbitration as set forth above, and not litigation, are the only dispute resolution
procedures that will be used for disputes, controversies or claims arising as a result of this Agreement. 
 Notwithstanding anything
contained hereunder, Client agrees and acknowledges that no dispute resolution shall be pursued by Client for any breach of this Agreement until and unless DevFactory has had an opportunity to cure any alleged breach. Client agrees to provide
DevFactory with a detailed description of any alleged failure and description of the steps that Client understands must be taken by DevFactory to resolve the failure. DevFactory shall have thirty (30) days from DevFactory’s receipt of
Client’s notice to complete and cure. 
 12.17 Choice of Law. THIS AGREEMENT SHALL BE GOVERNED AND INTERPRETED BY THE LAWS OF THE STATE OF
TEXAS, USA, WITHOUT REGARD TO THE CONFLICTS OF LAW PROVISIONS OF ANY STATE OR JURISDICTION. 

 

  

			
	Technology Services Agreement	  	Page 6

 The parties hereto agree to the foregoing as evidenced by their signatures below. 

Agreed to by: 
  

			
	 DEVFACTORY FZ-LLC
	  	 UPLAND SOFTWARE, INC.

	(DevFactory)	  	(“Client”)
		
	 /s/ RAHUL SUBRAMANIAM
	  	 /s/ JOHN T. MCDONALD

	Signature	  	Signature
		
	 Rahul Subramaniam
	  	 John T. McDonald

	Print Name	  	Print Name
		
	 CEO
	  	 Chief Executive Officer

	Title	  	Title
		
	 January 26, 2014
	  	 January 26, 2014

	Date	  	Date

 DevFactory Legal Approval  ̈

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]